Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GREEN LIGHT: Intra-operative fluorescent imaging of sentinel lymph nodes in breast cancer
2008-007474-38Phase 2Active
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indocyanine green in breast cancer, sponsored by Leiden University Medical Center. Primary endpoint: Sentinel and non-sentinel lymph node identification rate by fluorescent imaging. Started Dec 2008; status: active.
02
Drugs
indocyanine green
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2008-007474-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007474-38.